ReversingLabs, Inc. — Form D
ReversingLabs, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-15. The offering totals $62.8M, of which $38.6M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-05-15
- Form: D
- Accession: 0001724209-24-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $62.8M
- Amount sold: $38.6M
- Remaining: $24.1M
- Investors: 3
- Date of first sale: 2024-04-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-513327
Issuer
- Name: ReversingLabs, Inc.
- CIK: 0001724209
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 222 THIRD STREET, UNIT 1101, CAMBRIDGE, MA, 02142
- Phone: 6172507518
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| GREG CLARK | Director | SAN JOSE, CA |
| Douglas Levin | Director | Sudbury, MA |
| Tomislav Pericin | Director | Cambridge, MA |
| Hugh Thompson | Director | Cambridge, MA |
| Mario Vuksan | Director | Cambridge, MA |
| Alberto Yepez | Director | Cambridge, MA |
| Mario Vuksan | Executive Officer | Cambridge, MA |
| SEAN CUNNINGHAM | Director | CHICAGO, IL |
| W. Patrick Opet | Director | Cambridge, MA |
Other filings by this issuer (2)
More